This brand name is authorized in Spain, Japan, South Africa
The drug LORAMET contains one active pharmaceutical ingredient (API):
|
1
Lormetazepam
UNII GU56C842ZA - LORMETAZEPAM
|
|
Lormetazepam is a benzodiazepine with anxiolytic, muscle relaxant, sedative and hypnotic properties. Clinical studies have shown minimal effects on REM sleep and on psychomotor performance on the day after treatment with lormetazepam. Lormetazepam is indicated for the short term treatment of insomnia. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CD06 | Lormetazepam | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 56293, 58639 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1124010F1030 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): S/2.2/0215, S/2.2/0216 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
